· investment-strategies  · 2 min read

June 2026 NYC VC Roundup: $75M+ in New Fund Closes, Hypha's $50M Seed, and Elbow Grease

June 2026 New York venture activity spans new fund closes from Gutter Capital and Animal Capital, a medtech debut from Star51, and mega-seed rounds in private markets AI.

June 2026 was a fund-formation month in New York as much as a deal month. Gutter Capital, Animal Capital, and Star51 Capital all announced new vehicles while Hypha AI and Interchecks posted headline rounds.

Mega rounds and breakout seeds

CompanyRoundAmountCategory
Hypha AISeed$50MPrivate markets asset intelligence
InterchecksSeries C$50MFintech payments infrastructure
ProbookSeed + Series A$40MAI for home services
Podium AutomationSeries A$18MManufacturing control panels
F2 AI$14MAI infrastructure
PreciseSeed$7MHealthcare/clinical
KimbaSeed$6.5MConsumer tech
ChptrSeries A$5.5MSocial/community
SwshSeed$4MFan engagement platform

NYC new fund closes (June 2026)

FirmFundSizeFocus
Gutter CapitalFund III$75MEarly-stage + Elbow Grease accelerator
Animal CapitalFund III$33MConsumer tech, creator economy
Blue Cloud VenturesFund VUndisclosed ($1B+ AUM)Enterprise SaaS/AI growth
Star51 CapitalFund I (first close)UndisclosedMedtech + AI, Abbott/Mayo anchored
Dimension CapitalFund III (raising)Up to $750M targetML × life sciences
RelentlessFund I$80M+Seed, concentrated portfolio
Opto InvestmentsAI FundUndisclosedRIA/family office AI vehicle (May 28)
Eckuity CapitalFund II (first close)UndisclosedHealthcare growth equity
Colbeck CapitalStrategic Income~$400MNYC private credit/direct lending

Investor moves worth tracking

  • Gutter Capital pivoted its entire firm around Elbow Grease, a 10-week NYC accelerator offering $300K per team — applications close July 31, 2026.
  • Animal Capital LP roster includes Paris Hilton, MrBeast, Justin Kan, and Gary Cohn — signaling continued celebrity-capital convergence in consumer tech.
  • Star51 Capital structured as an operator-led ecosystem fund with Abbott and Mayo Clinic as anchor LPs.
  • Dimension Capital filed SEC Form D for Fund III at up to $750M, following $350M Fund I (2023) and $500M Fund II (2024).

Pattern recognition

  1. Accelerator-as-fund-strategy — Gutter’s $75M Fund III is explicitly tied to hands-on NYC cohort investing, not passive spray-and-pray.
  2. Private markets AI gets mega-seed — Hypha’s $50M seed from real estate and credit investors signals category conviction beyond traditional VC.
  3. Medtech ecosystem funds — Star51’s operator-LP model reflects NYC’s strength in healthcare strategics as co-investors.
  4. Life sciences dry powder keeps growing — Dimension’s $750M target would make it one of the largest NYC life sciences vehicles.

Practical takeaway

Founders: Gutter’s Elbow Grease cohort (deadline July 31) and Animal Capital’s consumer thesis are active NYC paths for early capital. Investors: June confirmed NYC manager formation in medtech, consumer, and life sciences — not just fintech and enterprise SaaS. LPs: Fund size discipline (Gutter $75M, Animal $33M) contrasts with Dimension’s ambitious $750M raise, reflecting a barbell in manager selection.

Sources

  1. AlleyWatch (June 15, 2026 funding report): https://alleywatch.com/2026/06/the-alleywatch-startup-daily-funding-report-6-15-2026/
  2. PR Newswire (Gutter Capital Fund III): https://www.prnewswire.com/news-releases/gutter-capital-announces-75m-fund-iii-opens-applications-for-elbow-grease-accelerator-302799970.html
  3. VCWire (Animal Capital Fund III): https://vcwire.tech/2026/06/11/animal-capital-closes-fund-iii-at-33m/
  4. PR Newswire (Star51 Capital): https://www.prnewswire.com/news-releases/star51-capital-announces-first-close-of-medtech-venture-fund-302798225.html
  5. Endpoints News (Dimension Capital Fund III): https://endpoints.news/dimension-seeks-up-to-750m-for-third-life-sciences-fund-after-string-of-success/
  6. Venture5 (June 14–20 VC moves): https://venture5.com/vc-moves/newsletters/wrapups/moves-in-vc-week-of-june-14-june-20/
  7. FinSMEs (Probook, Swsh): https://www.finsmes.com/

Frequently Asked Questions

Common questions about this topic

Back to Blog

Related Posts

View All Posts »